Post-approval studies (Phase 4)Active Not RecruitingNCT07109297
What this trial is testing
Study of Monoclonal Antibody Nirsevimab Against Respiratory Syncytial Virus (RSV) in Participants up to 24 Months of Age in India
Who this might be right for
RSV Immunization
Sanofi 110